These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3450771)

  • 21. [Immunologic studies of the role of cholinergic receptors in the pathogenesis of myasthenia gravis].
    Członkowski A; Członkowska A
    Neurol Neurochir Pol; 1978; 12(5):633-7. PubMed ID: 214726
    [No Abstract]   [Full Text] [Related]  

  • 22. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT
    Br Med J (Clin Res Ed); 1983 Jan; 286(6362):338-40. PubMed ID: 6402089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
    Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
    Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerulonephritis, thymoma and myasthenia gravis.
    Scadding GK; Sweny P; Wilson SG; Havard CW; Newsom-Davis J
    Q J Med; 1983; 52(206):187-93. PubMed ID: 6611840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remarkably increased resistin levels in anti-AChR antibody-positive myasthenia gravis.
    Zhang DQ; Wang R; Li T; Li X; Qi Y; Wang J; Yang L
    J Neuroimmunol; 2015 Jun; 283():7-10. PubMed ID: 26004149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of thymoma in myasthenia gravis.
    Keesey J; Bein M; Mink J; Sample F; Sarti D; Mulder D; Herrmann C; Peter JB
    Neurology; 1980 Mar; 30(3):233-9. PubMed ID: 7189022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.
    Ohta K; Shigemoto K; Kubo S; Maruyama N; Abe Y; Ueda N; Ohta M
    Neurology; 2004 Jun; 62(11):2132-3. PubMed ID: 15184636
    [No Abstract]   [Full Text] [Related]  

  • 28. Autoantibodies in D-penicillamine-induced myasthenia gravis: a comparison with idiopathic myasthenia and rheumatoid arthritis.
    Morel E; Feuillet-Fieux MN; Vernet-der Garabedian B; Raimond F; D'Anglejan J; Bataille R; Sany J; Bach JF
    Clin Immunol Immunopathol; 1991 Mar; 58(3):318-30. PubMed ID: 2001604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.
    Penn AS; Schotland DL; Lamme S
    Muscle Nerve; 1986 Jun; 9(5):407-15. PubMed ID: 3724787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathogenesis, diagnosis, and treatment of myasthenia (review of the foreign literature)].
    Vasil'ev VN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(11):1729-34. PubMed ID: 7006280
    [No Abstract]   [Full Text] [Related]  

  • 31. Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies.
    Masters CL; Dawkins RL; Zilko PJ; Simpson JA; Leedman RJ
    Am J Med; 1977 Nov; 63(5):689-94. PubMed ID: 930944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in clinical and immunological status after post-thymectomized irradiation for invasive thymoma with myasthenia gravis].
    Ishida S
    Rinsho Shinkeigaku; 1996 May; 36(5):629-32. PubMed ID: 8905980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-ryanodine receptor antibody and the thymus gland in myasthenia gravis].
    Iwasa K; Asaka T; Takamori M
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):655-63. PubMed ID: 9627474
    [No Abstract]   [Full Text] [Related]  

  • 34. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies and HLA antigens in ocular, generalized and penicillamine-induced myasthenia gravis.
    Dawkins RL; Christiansen FT; Garlepp MJ
    Ann N Y Acad Sci; 1981; 377():372-84. PubMed ID: 6951482
    [No Abstract]   [Full Text] [Related]  

  • 36. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.
    Smith CI; Aarli JA; Hammarström L; Persson MA
    Neurology; 1984 Aug; 34(8):1094-6. PubMed ID: 6540388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gm allotypes in myasthenia gravis.
    Nakao Y; Matsumoto H; Miyazaki T; Nishitani H; Ota K; Fujita T; Tsuji K
    Lancet; 1980 Mar; 1(8170):677-80. PubMed ID: 6103092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Myasthenia gravis and antiacetylcholine receptor antibody (author's transl)].
    Ota M; Hayashi K
    Horumon To Rinsho; 1979 Aug; 27(8):833-42. PubMed ID: 385178
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiacetylcholine receptor antibodies and myasthenia gravis.
    Richter PL
    JAMA; 1982 Jun; 247(22):3082-3. PubMed ID: 7077800
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.